Media
Press Releases
March 25, 2026
Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets
February 26, 2026
Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans
February 24, 2026
Lupin Announces the Approval and Launch of Brivaracetam Oral Solution in the United States
February 16, 2026
Lupin Signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex™ in Canada
February 13, 2026
Anand Kripalu Joins Lupin Board as Independent Director
February 4, 2026
Lupin Launches Topiramate Extended-Release Capsules in the United States
February 2, 2026
Lupin Launches Dasatinib Tablets in the United States
February 2, 2026
Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases
January 21, 2026
Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries
Media
Rajalakshmi Azariah
Vice President & Global Head - Corporate Communications
rajalakshmiazariah@lupin.comElise Titan
Director, U.S. Communications
elisetitan@lupin.comSmart Guide
Close
CloseSearch Product
Global Privacy Control Detected
We have detected your Global Privacy Control (GPC) signal. In accordance with applicable privacy laws, we have automatically honored your preference and disabled all non-essential cookies and tracking.
Only necessary cookies required for the website to function are enabled.
Opt-Out Request Honored
We have respected your privacy preference. Your opt-out request through cookie settings or Global Privacy Control signal has been honored.